Skip to main content

AI assistant

Sign in to chat with this filing

The assistant answers questions, extracts KPIs, and summarises risk factors directly from the filing text.

BIOVIE INC. Director's Dealing 2021

Sep 28, 2021

35090_dirs_2021-09-28_eb4d3d9d-be75-42a7-9344-3f5306706fa6.zip

Director's Dealing

Open in viewer

Opens in your device viewer

SEC Form 4 — Statement of Changes in Beneficial Ownership

Issuer: BIOVIE INC. (BIVI)
CIK: 0001580149
Period of Report: 2020-12-18

Reporting Person: Hariri Robert J (Director)

Derivative Transactions

Date Security Exercise Price Code Shares A/D Expiration Underlying Ownership
2020-12-18 Stock Option (right to buy) $13.91 A 95900 Acquired 2025-12-18 Common Stock (95900) Direct

Footnotes

F1: This option was 25% vested upon grant, with an additional 25% on each of the first three anniversaries of the grant.